Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia

Sawyers, 1999, Chronic myeloid leukemia, N. Engl. J. Med., 340, 1330, 10.1056/NEJM199904293401706 Geary, 2000, The story of chronic myeloid leukaemia, Br. J. Haematol., 110, 2, 10.1046/j.1365-2141.2000.02137.x Druker, 2001, Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome, N. Engl. J. Med., 344, 1038, 10.1056/NEJM200104053441402 Deininger, 2000, The molecular biology of chronic myeloid leukemia, Blood, 96, 3343, 10.1182/blood.V96.10.3343 Herman, 2003, Gene silencing in cancer in association with promoter hypermethylation, N. Engl. J. Med., 349, 2042, 10.1056/NEJMra023075 Kawamoto, 2008, DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines, Int. J. Canc., 123, 535, 10.1002/ijc.23514 Oberwalder, 2008, SFRP2 methylation in fecal DNA–a marker for colorectal polyps, Int. J. Colorectal Dis., 23, 15, 10.1007/s00384-007-0355-2 Chen, 2018, Chemoprevention of colorectal cancer by black raspberry anthocyanins involved the modulation of gut microbiota and SFRP2 demethylation, Carcinogenesis, 39, 471, 10.1093/carcin/bgy009 Liu, 2017, Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer, Oncotarget, 8, 36354, 10.18632/oncotarget.16754 Xiao, 2015, Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells, Oncol. Rep., 34, 2259, 10.3892/or.2015.4221 Hehlmann, 2005, Chronic myeloid leukemia: a model for oncology, Ann. Hematol., 84, 487, 10.1007/s00277-005-1039-z Druker, 2001, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, N. Engl. J. Med., 344, 1031, 10.1056/NEJM200104053441401 Deininger, 2005, The development of imatinib as a therapeutic agent for chronic myeloid leukemia, Blood, 105, 2640, 10.1182/blood-2004-08-3097 Pereira, 2017, BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy, Cell Death Dis., 8, e3114, 10.1038/cddis.2017.458 Heller, 2016, Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia, Leukemia, 30, 1861, 10.1038/leu.2016.143 DDA, 2018, A.O. 0000-0002-9644-7098, MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia, Canc. Cell Int., 18, 26, 10.1186/s12935-018-0523-1 Jost, 2008, Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia, Br. J. Haematol., 142, 745, 10.1111/j.1365-2141.2008.07242.x Cheng, 2011, Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia, Blood, 118, 6638, 10.1182/blood-2011-05-354712 Urakami, 2006, Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA, Clin. Canc. Res., 12, 6989, 10.1158/1078-0432.CCR-06-1194 Konac, 2013, DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/beta-catenin signal pathway in a renal cell carcinoma cell line, Exp. Biol. Med. (Maywood), 238, 1009, 10.1177/1535370213498984 Kaur, 2016, sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance, Nature, 532, 250, 10.1038/nature17392 Wodarz, 1998, Mechanisms of Wnt signaling in development, Annu. Rev. Cell Dev. Biol., 14, 59, 10.1146/annurev.cellbio.14.1.59 Valencia, 2009, Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia, Leukemia, 23, 1658, 10.1038/leu.2009.86